Rating History for Cytokinetics (CYTK) by UBS

More Stocks Rated by UBS | Latest Ratings for CYTK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/29/2026 Ashwani Verma Upgrade Buy
(Neutral)		 115.00
(69.00)		 80.80
(71.40)		 -11.63% Details